GrowingStockReport.com

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and DURECT Corporation (NASDAQ:DRRX) Added to Growing Stock Report's NASDAQ Decliners Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 04/10/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and DURECT Corporation (NASDAQ:DRRX).

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) a development stage pharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceutical products closed down in its previous session (-9.09%) on 1,345,413 shares traded. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) is currently down (-27.59%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)

DURECT Corporation (NASDAQ:DRRX) a specialty pharmaceutical company that develops pharmaceutical systems technologies based on its proprietary drug delivery technology platforms closed down in its previous session (-5.80%) on 328,697 shares traded. DURECT Corporation (NASDAQ:DRRX) is currently down (-24.56%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Decliners Watch List.

Click Here to find out what other Investors are saying about DURECT Corporation (NASDAQ:DRRX)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com